K O S PHARMACEUTICALS INC
KOSP
KOSP was delisted on the 14th of December, 2006.
1 hedge funds and large institutions have $58.3K invested in K O S PHARMACEUTICALS INC in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
14% more capital invested
Capital invested by funds: $51K → $58.3K (+$7.3K)
0% more funds holding
Funds holding: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RWM
RMG Wealth Management
Platteville,
Wisconsin
|
+$5.53K |
Top Sellers
KOSP Hedge Fund Activity: Q3 2025 in Review
1 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in K O S PHARMACEUTICALS INC (KOSP) for Q3 2025, worth a combined $58.3K — up 14% from $51K a quarter earlier.
Fund positioning in KOSP was balanced in Q3 2025: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was RMG Wealth Management, adding an estimated $5.53K.
- 1 institutional investor held K O S PHARMACEUTICALS INC (KOSP) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $58.3K of K O S PHARMACEUTICALS INC stock for Q3 2025, up 14% quarter-over-quarter.
- 0 funds opened new K O S PHARMACEUTICALS INC positions in Q3 2025 and 0 closed out.
- The largest K O S PHARMACEUTICALS INC buyer in Q3 2025 was RMG Wealth Management, an estimated $5.53K added.
Based on aggregated 13F filings for Q3 2025.